Publication | Closed Access

Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis

VaccinologyVaccinationPulmonary TuberculosisVaccine DevelopmentVaccine ResearchM. TuberculosisVaccine TargetTuberculosis PreventionPathogenesisImmunologyTuberculosisVaccine DesignImmunotherapyMedicineMycobacterial Heparin-binding HaemagglutininBcg-vaccinated Newborn Mice